Supreme Court · 2019 INSC 947 · Decided 22 August 2019
Union of India & ANR. ETC. v. BGP Products Operations Gmbh and Hagene Immermatt WEG. & ANR. ETC.
- Court
- Supreme Court of India
- Citation
- 2019 INSC 947 · [2019] 11 S.C.R. 170
- Case number
- CIVIL APPEAL No. 6588/2019
- Decided
- 22 August 2019
- Bench
- ABHAY MANOHAR SAPRE, INDU MALHOTRA (2-judge bench)
- Outcome
- Matter referred to larger bench
- Case type
- Civil
- Acts & sections cited
- Constitution Article 14
Headnote
Drugs and Cosmetics Act, 1940: s.26-A - Notification dated 27.04.2018 issued under s.26A of the Act by the Ministry of Health and Family Welfare - Validity of Notification challenged in these appeals - the manufacture of Oxytocin formulations for domestic use, only by public sector undertakings or companies, to the complete exclusion of the private sector companies while the manufacture of the drug for export purposes is kept open to both public and private sector companies - Held:
Judgments are the courts' own published copies, provided for study; they are not certified copies. Source: Indian Supreme Court & High Court Judgments, Dattam Labs (CC-BY-4.0)